Compass (NYSE:COMP), a technology-driven real estate brokerage services provider, closed Wednesday’s session at $11.85, up 9.37%. Compass IPO'd in 2021 and has fallen 41% since going public. Trading volume reached 94.7 million shares, which is approximately 647% above its three-month average of 12.7 million shares. Wednesday’s action reflected investors reacting to Compass’s raised fourth-quarter guidance, its sizable convertible notes plan, and ongoing attention on the pending Anywhere merger.
The S&P 500 slipped 0.34% to 6,922, while the Nasdaq Composite edged up 0.16% to 23,584. Within the Real Estate Services sector, rivals moved more modestly, with Zillow Group rising 2.39%, for example.
Compass announced the proposal of a $750 million convertible senior notes offering, which would be used to help fund its merger with Anywhere Real Estate. While this offering may dilute shareholder value somewhat, the market appears more optimistic about the potential of the newly merged real estate firm -- especially after shareholders approved the deal.
Adding further excitement to the stock today, management announced that the company would add 800 agents in the fourth quarter, while stating that Q4 guidance would fall closer to the higher end of its expectations. All in all, it seems like great news for Compass and Anywhere shareholders, but it may take a few quarters (or even years) for the dust to settle and determine just how powerful the merger could prove to be over the long haul.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 971%* — a market-crushing outperformance compared to 196% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of January 7, 2026.
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Zillow Group. The Motley Fool has a disclosure policy.